REDUCTION OF ALLOGENEIC TRANSPLANT MORBIDITY BY COMBINING PERIPHERAL-BLOOD AND BONE-MARROW PROGENITOR CELLS

Authors
NEMUNAITIS J ALBO V ZEIGLER ZR SHADDUCK RK ROSENFELD CS
Citation
J. Nemunaitis et al., REDUCTION OF ALLOGENEIC TRANSPLANT MORBIDITY BY COMBINING PERIPHERAL-BLOOD AND BONE-MARROW PROGENITOR CELLS, Leukemia & lymphoma, 10(4-5), 1993, pp. 405-406
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Leukemia & lymphoma → ACNP
ISSN journal
10428194
Volume
10
Issue
4-5
Year of publication
1993
Pages
405 - 406
Database
ISI
SICI code
1042-8194(1993)10:4-5<405:ROATMB>2.0.ZU;2-G
Abstract
One case has been reported of a patient undergoing allogeneic transpla ntation with peripheral blood progenitor cells (PBPCs) rather than bon e marrow.1 We now report the first case of a patient who underwent an allogeneic transplant with bone marrow combined with PBPCs.